Albert Esquirol

945 total citations
45 papers, 433 citations indexed

About

Albert Esquirol is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Albert Esquirol has authored 45 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 20 papers in Oncology and 11 papers in Immunology. Recurrent topics in Albert Esquirol's work include Hematopoietic Stem Cell Transplantation (32 papers), Polyomavirus and related diseases (13 papers) and Lymphoma Diagnosis and Treatment (9 papers). Albert Esquirol is often cited by papers focused on Hematopoietic Stem Cell Transplantation (32 papers), Polyomavirus and related diseases (13 papers) and Lymphoma Diagnosis and Treatment (9 papers). Albert Esquirol collaborates with scholars based in Spain, United States and Italy. Albert Esquirol's co-authors include Rodrigo Martino, Jorge Sierra, Irene García‐Cadenas, Pere Barba, David Valcárcel, Salut Brunet, Javier Briones, Silvana Novelli, José Luís Piñana and Ana Garrido and has published in prestigious journals such as Blood, AIDS and British Journal of Haematology.

In The Last Decade

Albert Esquirol

41 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Albert Esquirol Spain	13	297	199	81	75	73	45	433
Irene García‐Cadenas Spain	11	270 0.9×	198 1.0×	60 0.7×	84 1.1×	94 1.3×	45	407
Olga Militano United States	12	247 0.8×	176 0.9×	134 1.7×	54 0.7×	57 0.8×	42	446
Sandeep Nagra United Kingdom	13	351 1.2×	143 0.7×	108 1.3×	134 1.8×	65 0.9×	21	518
Sameh Ayari France	12	232 0.8×	144 0.7×	71 0.9×	71 0.9×	72 1.0×	23	345
Radwan Massoud Lebanon	12	245 0.8×	158 0.8×	78 1.0×	88 1.2×	37 0.5×	51	397
Pınar Ataca Atilla Türkiye	9	200 0.7×	186 0.9×	35 0.4×	65 0.9×	97 1.3×	18	383
Sergey N. Bondarenko Russia	9	335 1.1×	112 0.6×	132 1.6×	144 1.9×	30 0.4×	117	466
Hakan Koç Türkiye	10	216 0.7×	96 0.5×	56 0.7×	66 0.9×	75 1.0×	38	369
Geothy Chakupurakal Germany	12	156 0.5×	126 0.6×	44 0.5×	157 2.1×	31 0.4×	28	369
Ryoko Yamasaki Japan	11	166 0.6×	116 0.6×	37 0.5×	55 0.7×	67 0.9×	33	314

Countries citing papers authored by Albert Esquirol

Since Specialization

Citations

This map shows the geographic impact of Albert Esquirol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Esquirol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Esquirol more than expected).

Fields of papers citing papers by Albert Esquirol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Esquirol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Esquirol. The network helps show where Albert Esquirol may publish in the future.

Co-authorship network of co-authors of Albert Esquirol

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Esquirol. A scholar is included among the top collaborators of Albert Esquirol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Esquirol. Albert Esquirol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caballero, A, Irene García‐Cadenas, Albert Esquirol, et al.. (2025). HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma. Blood. 145(16). 1788–1801.

Esquirol, Albert, María Pascual, Juan Montoro, et al.. (2024). Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil. Transplantation and Cellular Therapy. 30(10). 1025.e1–1025.e14.

García‐Cadenas, Irene, Albert Esquirol, Silvana Saavedra, et al.. (2024). Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation. European Journal Of Haematology. 113(6). 776–787. 1 indexed citations

Moga, Esther, Sílvia Vidal, Iria González, et al.. (2023). mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect. Leukemia Research. 132. 107347–107347. 2 indexed citations

Rafii, Hanadi, Annalisa Ruggeri, Chantal Kenzey, et al.. (2022). Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe. Blood Advances. 7(10). 1976–1986. 1 indexed citations

Esquirol, Albert, Iria González, Joaquín López‐Contreras, et al.. (2022). mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients. Supportive Care in Cancer. 30(12). 9687–9690. 3 indexed citations

Cid, Joan, Silvia Monsalvo, Cristina Pascual, et al.. (2021). Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH). Transfusion and Apheresis Science. 60(2). 103052–103052. 8 indexed citations

Esquirol, Albert, María Pascual, Mi Kwon, et al.. (2021). Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transplantation. 56(10). 2432–2444. 42 indexed citations

Fox, María Laura, Irene García‐Cadenas, Ariadna Pérez, et al.. (2020). Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis. Leukemia & lymphoma. 61(8). 1823–1832. 2 indexed citations

10.

Garrido, Ana, Elena Bussaglia, Marta Pratcorona, et al.. (2019). Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients. European Journal Of Haematology. 103(3). 208–214. 6 indexed citations

11.

Cuéllar‐García, Carolina, Salut Brunet, Javier Briones, et al.. (2018). Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy. Clinical Lymphoma Myeloma & Leukemia. 18(11). 737–742. 2 indexed citations

12.

Pérez-Simón, Josè Antonio, Mats Remberger, Teresa Caballero‐Velázquez, et al.. (2018). Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting. Medical Oncology. 35(6). 79–79. 12 indexed citations

13.

Barba, Pere, Rodrigo Martino, Qin Zhou, et al.. (2018). CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 24(5). 964–972. 16 indexed citations

14.

Barata, Anna, Rodrigo Martino, Ignasi Gich, et al.. (2017). Do Patients and Physicians Agree When They Assess Quality of Life?. Biology of Blood and Marrow Transplantation. 23(6). 1005–1010. 6 indexed citations

15.

Novelli, Silvana, Irene García‐Cadenas, A Caballero, et al.. (2017). Allogeneic hematopoietic stem cell transplantation for non-Hodgkin’s lymphomas: a retrospective analysis of 77 cases. Annals of Hematology. 96(5). 787–796. 3 indexed citations

16.

Esquirol, Albert, María Pascual, José Luís Piñana, et al.. (2017). Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies. Bone Marrow Transplantation. 52(9). 1273–1279. 13 indexed citations

17.

Kharfan‐Dabaja, Mohamed A., Rocío Parody, Janelle Perkins, et al.. (2016). Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation. Bone Marrow Transplantation. 52(3). 438–444. 8 indexed citations

18.

García‐Cadenas, Irene, Rodrigo Martino, Albert Esquirol, et al.. (2016). Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease. Bone Marrow Transplantation. 52(1). 107–113. 38 indexed citations

19.

García‐Cadenas, Irene, Rodrigo Martino, Pere Barba, et al.. (2015). Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab. Bone Marrow Transplantation. 50(4). 579–584. 45 indexed citations

20.

Esquirol, Albert, et al.. (2012). Foetal-neonatal alloimmune thrombocytopenia due to anti-HPA-2b antibodies present in the serum of a mother initially mistyped as HPA-1a negative.. PubMed. 10(3). 390–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact